Michael D. West - 04 Jun 2021 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Chief Executive Officer, Director
Signature
/s/Michael D. West
Issuer symbol
SER
Transactions as of
04 Jun 2021
Net transactions value
$0
Form type
4
Filing time
08 Jun 2021, 19:20:15 UTC
Next filing
15 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Option to Purchase Common Stock Award $0 +120,000 $0.000000 120,000 04 Jun 2021 Common Stock 120,000 $1.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date.